Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.
暂无分享，去创建一个
V. Gebski | G. Kristensen | K. Lindemann | M. Mirza | G. Creemers | A. Burges | A. Ayhan | E. Pujade-Lauraine | M. Huizing | F. Hilpert | F. Raspagliesi | I. Romero | M. Rubio | L. Davies | M. Lykka | C. Lee